CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-21 | Harris Todd Chief Executive Officer | Sale | −12,393 | $16.00 | $198K | 1,701,276 |
| 2023-03-21 | Harris Todd Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −12,393 | 416,619 | ||
| 2023-03-21 | Bensen Daniel Chief Operating Officer | Option exercise | +14,100 | $0.61 | $9K | 542,081 |
| 2023-03-21 | Bensen Daniel Chief Operating Officer | Sale | −14,100 | $16.00 | $226K | 527,981 |
| 2023-03-21 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −14,100 | 256,029 | ||
| 2023-03-15 | Harris Todd Chief Executive Officer | Grant or award | +1,808 | $6.58 | $12K | 1,701,276 |
| 2023-03-15 | Tada Hiroomi Chief Medical Officer | Grant or award | +1,893 | $6.58 | $12K | 83,130 |
| 2023-02-21 | Patel Piyush R. Chief Development Officer | Gift | −8,442 | 73,794 | ||
| 2023-02-10 | MVA Investors, LLC 10% owner | Sale | −65,568 | $13.40 | $879K | 22,527 |
| 2023-02-09 | MVA Investors, LLC 10% owner | Sale | −200,000 | $13.10 | $2.6M | 88,095 |
| 2023-01-01 | Fuhrman Alan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +32,800 | 32,800 | ||
| 2023-01-01 | Fuhrman Alan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +328,000 | 328,000 | ||
| 2022-10-12 | Patel Piyush R. Chief Development Officer | Gift | −56,276 | 82,236 | ||
| 2022-09-15 | van den Boom Esther Chief Financial Officer | Grant or award | +1,452 | $7.66 | $11K | 121,897 |
| 2022-09-15 | Tada Hiroomi Chief Medical Officer | Grant or award | +612 | $7.66 | $5K | 81,237 |
| 2022-09-15 | Patel Piyush R. Chief Development Officer | Grant or award | +1,040 | $7.66 | $8K | 138,512 |
| 2022-09-15 | Hudkins Robert L. Chief Technology Officer | Grant or award | +1,040 | $7.66 | $8K | 273,576 |
| 2022-09-06 | van den Boom Esther Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2022-09-06 | van den Boom Esther Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +89,054 | 89,054 | ||
| 2022-09-06 | Tada Hiroomi Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 |
Page 16 of 21 · 417 trades